109 related articles for article (PubMed ID: 26517355)
1. HER3 over-expression and overall survival in gastrointestinal cancers.
Wang Y; Yang H; Duan G
Oncotarget; 2015 Dec; 6(40):42868-78. PubMed ID: 26517355
[TBL] [Abstract][Full Text] [Related]
2. HER3 overexpression and survival in solid tumors: a meta-analysis.
Ocana A; Vera-Badillo F; Seruga B; Templeton A; Pandiella A; Amir E
J Natl Cancer Inst; 2013 Feb; 105(4):266-73. PubMed ID: 23221996
[TBL] [Abstract][Full Text] [Related]
3. Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients.
Luo Y; Zhang X; Tan Z; Wu P; Xiang X; Dang Y; Chen G
PLoS One; 2015; 10(12):e0145659. PubMed ID: 26710214
[TBL] [Abstract][Full Text] [Related]
4. Association between the overexpression of Her3 and clinical pathology and prognosis of colorectal cancer: A meta-analysis.
Yan Q; Guo K; Feng G; Shan F; Sun L; Zhang K; Shen F; Shen M; Ruan S
Medicine (Baltimore); 2018 Sep; 97(37):e12317. PubMed ID: 30212974
[TBL] [Abstract][Full Text] [Related]
5. Neuregulin expression in solid tumors: prognostic value and predictive role to anti-HER3 therapies.
Ocaña A; Díez-González L; Esparís-Ogando A; Montero JC; Amir E; Pandiella A
Oncotarget; 2016 Jul; 7(29):45042-45051. PubMed ID: 27074567
[TBL] [Abstract][Full Text] [Related]
6. High expression of HER3 is associated with a decreased survival in gastric cancer.
Hayashi M; Inokuchi M; Takagi Y; Yamada H; Kojima K; Kumagai J; Kawano T; Sugihara K
Clin Cancer Res; 2008 Dec; 14(23):7843-9. PubMed ID: 19047113
[TBL] [Abstract][Full Text] [Related]
7. HER3 expression is correlated to distally located and low-grade colon cancer.
Lédel F; Stenstedt K; Hallström M; Ragnhammar P; Edler D
Acta Oncol; 2016 Jul; 55(7):875-80. PubMed ID: 26863446
[TBL] [Abstract][Full Text] [Related]
8. HER3, but Not HER4, Plays an Essential Role in the Clinicopathology and Prognosis of Gastric Cancer: A Meta-Analysis.
Cao GD; Chen K; Xiong MM; Chen B
PLoS One; 2016; 11(8):e0161219. PubMed ID: 27536774
[TBL] [Abstract][Full Text] [Related]
9. ErbB-3 predicts survival in ovarian cancer.
Tanner B; Hasenclever D; Stern K; Schormann W; Bezler M; Hermes M; Brulport M; Bauer A; Schiffer IB; Gebhard S; Schmidt M; Steiner E; Sehouli J; Edelmann J; Läuter J; Lessig R; Krishnamurthi K; Ullrich A; Hengstler JG
J Clin Oncol; 2006 Sep; 24(26):4317-23. PubMed ID: 16896008
[TBL] [Abstract][Full Text] [Related]
10. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
[TBL] [Abstract][Full Text] [Related]
11. Nuclear HER3 is associated with favorable overall survival in uveal melanoma.
Trocmé E; Mougiakakos D; Johansson CC; All-Eriksson C; Economou MA; Larsson O; Seregard S; Kiessling R; Lin Y
Int J Cancer; 2012 Mar; 130(5):1120-7. PubMed ID: 21484789
[TBL] [Abstract][Full Text] [Related]
12. HER3 expression in patients with primary colorectal cancer and corresponding lymph node metastases related to clinical outcome.
Lédel F; Hallström M; Ragnhammar P; Öhrling K; Edler D
Eur J Cancer; 2014 Feb; 50(3):656-62. PubMed ID: 24300455
[TBL] [Abstract][Full Text] [Related]
13. Association between raf kinase inhibitor protein loss and prognosis in cancers of the digestive system: a meta-analysis.
Yu M; Wang Q; Ding JW; Yang Z; Xie C; Lu NH
Cancer Biomark; 2014; 14(5):389-400. PubMed ID: 25171481
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Expression of Cyclin E in Gastrointestinal Cancer: A Systematic Review and Meta-Analysis.
Huang L; Ren F; Tang R; Feng Z; Chen G
Technol Cancer Res Treat; 2016 Feb; 15(1):12-9. PubMed ID: 25627202
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
[TBL] [Abstract][Full Text] [Related]
16. HER3 overexpression as an independent indicator of poor prognosis for patients with curatively resected pancreatic cancer.
Hirakawa T; Nakata B; Amano R; Kimura K; Shimizu S; Ohira G; Yamada N; Ohira M; Hirakawa K
Oncology; 2011; 81(3-4):192-8. PubMed ID: 22067729
[TBL] [Abstract][Full Text] [Related]
17. Sustained Inhibition of HER3 and EGFR Is Necessary to Induce Regression of HER2-Amplified Gastrointestinal Carcinomas.
Leto SM; Sassi F; Catalano I; Torri V; Migliardi G; Zanella ER; Throsby M; Bertotti A; Trusolino L
Clin Cancer Res; 2015 Dec; 21(24):5519-31. PubMed ID: 26296355
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis.
Zhao S; Qiu Z; He J; Li L; Li W
Int J Clin Exp Pathol; 2014; 7(10):6694-704. PubMed ID: 25400749
[TBL] [Abstract][Full Text] [Related]
19. The role of Human leukocyte antigen class I on patient survival in Gastrointestinal cancers: a systematic review and meta- analysis.
Najafimehr H; Hajizadeh N; Nazemalhosseini-Mojarad E; Pourhoseingholi MA; Abdollahpour-Alitappeh M; Ashtari S; Zali MR
Sci Rep; 2020 Jan; 10(1):728. PubMed ID: 31959894
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of LAMP3 and TP53 overexpression in benign and malignant gastrointestinal tissues.
Sun R; Wang X; Zhu H; Mei H; Wang W; Zhang S; Huang J
Oncotarget; 2014 Dec; 5(23):12398-409. PubMed ID: 25362357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
